128 related articles for article (PubMed ID: 37738795)
1. Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate.
Hu M; Xu M; Chen Y; Ye Z; Zhu S; Cai J; Zhang M; Zhang C; Huang R; Ye Q; Ao H
Biomed Pharmacother; 2023 Nov; 167():115541. PubMed ID: 37738795
[TBL] [Abstract][Full Text] [Related]
2. [Biological effects of toosendanin, an active ingredient of herbal vermifuge in Chinese traditional medicine].
Shi YL; Wang WP
Sheng Li Xue Bao; 2006 Oct; 58(5):397-406. PubMed ID: 17041722
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer effect of toosendanin and its underlying mechanisms.
Zhang S; Cao L; Wang ZR; Li Z; Ma J
J Asian Nat Prod Res; 2019 Mar; 21(3):270-283. PubMed ID: 29629572
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine.
Shi YL; Li MF
Prog Neurobiol; 2007 May; 82(1):1-10. PubMed ID: 17363132
[TBL] [Abstract][Full Text] [Related]
5. Toosendanin-induced apoptosis of CMT-U27 is mediated through the mitochondrial apoptotic pathway.
Yang Y; Mei C; Xian H; Zhang X; Li J; Liang ZX; Zhi Y; Ma Y; Wang HJ
Vet Comp Oncol; 2023 Jun; 21(2):315-326. PubMed ID: 36809669
[TBL] [Abstract][Full Text] [Related]
6. Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor.
Kai W; Yating S; Lin M; Kaiyong Y; Baojin H; Wu Y; Fangzhou Y; Yan C
Biochem Pharmacol; 2018 Jun; 152():153-164. PubMed ID: 29574068
[TBL] [Abstract][Full Text] [Related]
7. Toosendanin Shows Potent Efficacy Against Human Ovarian Cancer through Caspase-Dependent Mitochondrial Apoptotic Pathway.
Wang G; Fan XQ; Li L; Li Y; Shi B; Xing KX; Gao QL
Am J Chin Med; 2021; 49(7):1757-1772. PubMed ID: 34521317
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives.
Zhang H; Chen Y; Liu Q; Xiao WW; Shao LD; Pan ZH; Chen CH; Li D
Bioorg Med Chem Lett; 2023 Mar; 83():129187. PubMed ID: 36781147
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative analysis of toosendanin in Melia toosendan Sieb. Et Zucc (Meliaceae) with liquid chromatography/tandem mass spectrometry.
Ong ES; Ong CN
Rapid Commun Mass Spectrom; 2007; 21(4):589-98. PubMed ID: 17262897
[TBL] [Abstract][Full Text] [Related]
10. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
Wang G; Li L; Li Y; Zhang LH
Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of crude extract from Melia toosendan Sieb. et Zucc on hepatocellular carcinoma in vitro and in vivo.
Liu XL; Wang H; Zhang L; Wang YL; Wang J; Wang P; He X; He YJ
Chin J Integr Med; 2016 May; 22(5):362-9. PubMed ID: 26383159
[TBL] [Abstract][Full Text] [Related]
12. Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh.
Zhang M; Tao Z; Gao L; Chen F; Ye Y; Xu S; Huang W; Li X
Drug Dev Res; 2022 Aug; 83(5):1201-1211. PubMed ID: 35656621
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid and glutathione N-conjugates of toosendanin: bioactivation of the furan ring mediated by CYP3A4.
Yu J; Deng P; Zhong D; Chen X
Chem Res Toxicol; 2014 Sep; 27(9):1598-609. PubMed ID: 25105339
[TBL] [Abstract][Full Text] [Related]
14. Toosendanin induces apoptosis of MKN‑45 human gastric cancer cells partly through miR‑23a‑3p‑mediated downregulation of BCL2.
Shao S; Li S; Liu C; Zhang W; Zhang Z; Zhu S; Feng Y; Pan Y
Mol Med Rep; 2020 Sep; 22(3):1793-1802. PubMed ID: 32582989
[TBL] [Abstract][Full Text] [Related]
15. Toosendanin induces hepatotoxicity via disrupting LXRα/Lipin1/SREBP1 mediated lipid metabolism.
Chen S; Ni J; Luo L; Lin J; Peng H; Shen F; Huang Z
Food Chem Toxicol; 2024 May; 187():114631. PubMed ID: 38570025
[TBL] [Abstract][Full Text] [Related]
16. Toosendanin alleviates dextran sulfate sodium-induced colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2/HO-1 signaling.
Fan H; Chen W; Zhu J; Zhang J; Peng S
Int Immunopharmacol; 2019 Nov; 76():105909. PubMed ID: 31520988
[TBL] [Abstract][Full Text] [Related]
17. Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling.
Chen TX; Cheng XY; Wang Y; Yin W
Sci Rep; 2018 Mar; 8(1):4626. PubMed ID: 29545541
[TBL] [Abstract][Full Text] [Related]
18. Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis.
He Y; Wang J; Liu X; Zhang L; Yi G; Li C; He X; Wang P; Jiang H
Planta Med; 2010 Sep; 76(13):1447-53. PubMed ID: 20157879
[TBL] [Abstract][Full Text] [Related]
19. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
[TBL] [Abstract][Full Text] [Related]
20. Toosendanin induces hepatotoxicity by restraining autophagy and lysosomal function through inhibiting STAT3/CTSC axis.
Luo L; Ni J; Zhang J; Lin J; Chen S; Shen F; Huang Z
Toxicol Lett; 2024 Apr; 394():102-113. PubMed ID: 38460807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
